drugset / Trial / NCT00606801

Galantamine Effects on Cognitive Function in Abstinent Cocaine Users

NCT00606801

RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate galantamine's effects on cognitive performance in abstinent cocaine users. Galantamine, a medication approved for treatment of Alzheimer's disease, is an acetylcholine esterase inhibitor. Galantamine also directly potentiates nicotine receptors. Both of these effects may result in improved cognitive performance in a group of subjects known to have impaired performance in various cognitive tasks.

Timeline

Start
2007-06
Primary completion
2009-02
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Galantamine Small molecule 8 mg

Indications